NeuroVive Pharmaceutical ABのROIC
NeuroVive Pharmaceutical ABのROICは何ですか。
NeuroVive Pharmaceutical ABのROICは-152.24%です。
ROICの定義は何ですか。
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
OTCのセクタHealth CareにおけるROICの企業と比べるNeuroVive Pharmaceutical AB
NeuroVive Pharmaceutical ABは何をしますか。
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
NeuroVive Pharmaceutical ABと類似のroic
- PredictmedixのROICは-154.59%です。
- Helius Medical TechnologiesのROICは-154.03%です。
- Titan MedicalのROICは-153.87%です。
- Cardinal ResourcesのROICは-153.72%です。
- Ecc Ventures 3 CorpのROICは-153.21%です。
- Thin Film Electronics ASAのROICは-152.63%です。
- NeuroVive Pharmaceutical ABのROICは-152.24%です。
- URA PlcのROICは-152.11%です。
- Josemaria ResourcesのROICは-151.90%です。
- Canadian CannabisのROICは-151.48%です。
- Ximen MiningのROICは-150.81%です。
- Euro Sun MiningのROICは-150.66%です。
- Eskay MiningのROICは-150.63%です。